SCHEMBL25798651

SCHEMBL25798651

CCc1nc(-c2cccc(-c3ccc(-c4ccccc4)c4ccccc34)c2)nc(-c2ccccc2-c2cccc3ccccc23)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 5/20 0.39
PDE4D Q08499 4/20 0.39
PDE4A P27815 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE3B Q13370 3/20 0.39
PDE3A Q14432 3/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25798658 0.99 KDM4E (0.39) PDE4BPDE4DPDE4APDE4CPDE3B
SCHEMBL25798653 0.95 KDM4E (0.41) PDE4BPDE4DPDE4APDE4CPDE3B
SCHEMBL25798648 0.94 KDM4E (0.42) PDE4BPDE4DPDE4APDE4CPDE3B
SCHEMBL25798655 0.92 KDM4E (0.43) PDE4BPDE4DPDE4APDE4CPDE3B
SCHEMBL25798650 0.91 KDM4E (0.43) PDE4BPDE4DPDE4APDE4CPDE3B
SCHEMBL26562139 0.91 L3MBTL1 (0.46) PDE4BPDE4DKDM4EALDH1A1TP53
SCHEMBL25798670 0.88 MAPT (0.48) KDM4EALDH1A1TP53MAPTHPGD
SCHEMBL25798643 0.88 L3MBTL1 (0.41) PDE4BPDE4DPDE4APDE4CPDE3B
SCHEMBL25798638 0.88 L3MBTL1 (0.41) PDE4BPDE4DKDM4EALDH1A1TP53
SCHEMBL25798717 0.88 KDM4E (0.44) KDM4EALDH1A1TP53MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11696501-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-07-04 US disclosed
US-20230125420-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11696501-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, AGO2, AOC2 PDE4B 4362/4885PDE4D 4582/4885PDE4A 4452/4885
US-20230125420-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ETV6 PDE4B 4558/4885PDE4D 4683/4885PDE4A 4631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.